AIMMUNE THERAPEUTICS INC.
AIMMUNE THERAPEUTICS INC.
Ouverture: -
Variation: -
Volume: -
+ Bas: -
+ Haut: -
Ecart + Bas / + Haut: -
Type: Actions
Ticker: AIMT
ISIN:

Former Aimmune Therapeutics CEO: Taking Stock in Allergies | Mad Money | CNBC

  • 184
Roughly 15 million Americans have food allergies, including 5.9 million children under age 18. Jim Cramer talks to the recently retired CEO of Aimmune ...
CNBC